Join to View Full Profile
11140 Montgomery RdCincinnati, OH 45249
Phone+1 513-564-8580
Fax+1 513-564-8584
Dr. Firdaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 1996 - 1999
Des Moines University College of Osteopathic MedicineClass of 1995
Certifications & Licensure
OH State License 1999 - 2027
KY State License 2016 - 2026
IN State License 2020 - 2025
IL State License 1996 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Start of enrollment: 2009 Feb 01
Publications & Presentations
PubMed
- 67 citationsA randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancerZishuo Ian Hu, Johanna C. Bendell, Andrea J. Bullock, Noelle K. LoConte, Hassan Hatoum
Cancer Medicine. 2019-09-01 - 42 citationsA Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal CancerJohanna C. Bendell, Howard S. Hochster, Lowell L. Hart, Irfan Firdaus, Joseph R. Mace
The Oncologist. 2017-03-01 - 19 citationsPhase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction exp...Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A. Hubner
Investigational New Drugs. 2017-02-11
Press Mentions
New Collaboration at Christ Hospital Is Changing the Way Doctors Diagnose and Treat Cancer PatientsNovember 18th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
